How Independent Verification & Validation Protects Healthcare AI

When a healthcare AI system makes a recommendation that harms a patient, the question regulators and plaintiffs ask first is not "what did the algorithm decide?" — it is "who checked the algorithm?" Independent Verification and Validation (IV&V) is the formal answer to that question. It is also one of the most underutilized risk controls in modern healthcare AI development.

What Is IV&V in the Context of Healthcare AI?

Independent Verification and Validation is a structured quality assurance process in which a party with no conflict of interest evaluates whether a software system does what it is specified to do (verification) and whether it does the right thing for its intended purpose (validation). The independence requirement is not a formality. When the same team that builds a system also evaluates it, confirmation bias and organizational pressure routinely cause critical defects to survive into production.

In healthcare AI, IV&V carries additional weight because the systems being evaluated influence clinical decisions. A diagnostic AI that misclassifies a malignant lesion as benign, a clinical decision support tool that recommends a contraindicated medication, or a risk stratification model trained on biased data can directly cause patient harm. The cost of catching these failures after deployment — in patient safety terms, regulatory sanctions, and litigation — vastly exceeds the cost of a rigorous pre-deployment IV&V process.

The Regulatory Foundation for IV&V

Healthcare AI developers operate under overlapping regulatory frameworks that either require or strongly incentivize independent verification and validation.

The FDA's Software as a Medical Device (SaMD) framework, updated through its AI/ML Action Plan, requires that developers demonstrate their systems perform as intended across diverse patient populations before and after deployment. The FDA expects documented testing plans, performance benchmarks on held-out clinical datasets, and evidence that the system behaves safely at the boundary conditions it will encounter in real clinical environments. This is verification and validation by another name.

HIPAA's Security Rule (45 CFR §164.312) requires covered entities and their business associates to implement technical safeguards that protect electronic protected health information (ePHI). An AI system that processes ePHI — which includes virtually any clinical AI tool — must be evaluated for the security controls protecting that data. An AI code audit that examines how PHI flows through the codebase, where it is stored, and how it is transmitted is a direct compliance control under this requirement.

For organizations seeking Joint Commission accreditation or participating in CMS quality programs, documentation of third-party system evaluation increasingly appears in accreditation questionnaires as AI adoption accelerates.

What a Rigorous Healthcare AI IV&V Process Covers

A credible IV&V engagement for a healthcare AI system goes beyond running a test suite. It examines the system across five dimensions.

• Specification conformance — Does the system implement the clinical logic documented in its design specification? Gaps between specification and implementation are a leading source of silent failures in clinical AI.
• Data pipeline integrity — How does patient data enter the system, get transformed, and get used for inference? An AI code audit traces the full data lineage, identifying points where PHI is logged, cached, or transmitted without appropriate controls.
• Model performance under distribution shift — Does the model's documented performance hold when applied to patient populations that differ from the training cohort? This requires evaluating both the model artifacts and the code that orchestrates inference.
• Security posture — Are authentication and authorization controls correctly implemented? Are dependencies free of known critical vulnerabilities? Are secrets handled appropriately? Healthcare AI systems are high-value targets because they combine sensitive data with often-expedited development timelines.
• Failure mode analysis — What does the system do when the model returns a low-confidence prediction, when an upstream data source is unavailable, or when an input falls outside the expected range? Safe failure is a design requirement, not an afterthought.

The AI Code Audit as a Component of IV&V

Healthcare AI verification depends on understanding what the code actually does — not what the documentation says it does. An AI code audit provides the empirical foundation for verification claims. It examines the repository for implementation defects, security vulnerabilities, PHI handling failures, and dependency risks that would not surface in clinical performance testing alone.

Consider a common scenario: a clinical NLP tool that extracts diagnoses from clinical notes. Functional testing confirms it extracts diagnoses correctly. But a code audit reveals that extracted text, including fragments of patient notes, is written to an application log that is not covered by the organization's PHI retention and deletion policy. The clinical performance test passes. The HIPAA compliance requirement fails. Only the code audit catches this.

Building the IV&V Evidence Package

Regulators, institutional review boards, and legal teams increasingly require documented evidence that IV&V was performed. A complete evidence package includes the scope of the evaluation, the methodology used, the findings produced, how findings were remediated, and verification that remediations were effective. This documentation does not exist automatically — it must be deliberately constructed and retained.

For organizations building on commercial AI platforms or integrating large language models into clinical workflows, the IV&V scope must extend to the integration layer. The underlying model's safety profile, however well-documented by its developer, does not transfer to the integration. The code that wraps the model, routes its outputs into clinical systems, and governs when a clinician sees an AI recommendation is the layer where most real-world failures occur.

The Business Case for IV&V Investment

Healthcare organizations that have deployed AI systems without IV&V are accumulating undisclosed liability. A single high-profile adverse event linked to an AI system that lacked documented independent evaluation will produce regulatory scrutiny, litigation, and reputational damage that dwarfs the cost of a proactive IV&V program.

Beyond risk mitigation, IV&V accelerates procurement. Health systems evaluating vendor AI products now routinely ask for evidence of third-party security and compliance evaluation. An AI code audit report is a sales asset as much as a compliance artifact. Vendors who can present documented IV&V findings close enterprise deals faster than those who cannot.

How MergeProof Supports Healthcare AI Verification

MergeProof delivers AI code audits specifically designed for healthcare AI systems. Each audit covers PHI data flow analysis, security control verification, dependency vulnerability scanning, and compliance gap assessment against HIPAA technical safeguards and FDA SaMD expectations. Reports are structured to serve as IV&V evidence documentation — ready to present to regulators, institutional partners, and enterprise procurement teams.